title: Pure erythroid leukemia following precursor B-cell lymphoblastic leukemia.
abstract: Therapy-related acute myeloid leukemia is an unfortunate sequel to current multimodal intensive chemotherapy. The patient described was diagnosed with pure erythroleukemia, AML-M6b, during therapy for precursor B-cell acute lymphoblastic leukemia. To the best of our knowledge, this is the first report of this unusual association.
authors: Department of Laboratories, Seattle Children's Hospital, Seattle, WA, USA. min.xu@seattlechildrens.org
authors: Min
authors: M
authors: Xu
authors: Laura S
authors: LS
authors: Finn
authors: Karen D
authors: KD
authors: Tsuchiya
authors: Blythe
authors: B
authors: Thomson
authors: Jessica
authors: J
authors: Pollard
authors: Joe
authors: J
authors: Rutledge
mesh_terms: D059786:Abnormal Karyotype; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D001854:Bone Marrow Cells / Q000473:pathology; D002648:Child; D002999:Clone Cells; D017809:Fatal Outcome; D005260:Female; D006801:Humans; D016130:Immunophenotyping; D017404:In Situ Hybridization, Fluorescence; D004915:Leukemia, Erythroblastic, Acute / Q000175:diagnosis* / Q000188:drug therapy / Q000235:genetics; D016609:Neoplasms, Second Primary / Q000175:diagnosis* / Q000188:drug therapy / Q000235:genetics; D015452:Precursor B-Cell Lymphoblastic Leukemia-Lymphoma / Q000175:diagnosis* / Q000188:drug therapy / Q000235:genetics